The Universal Selection Source:
Coatings Ingredients
Industry News

VitroTech Corporation Announces Initial Production Order From Global Specialty Chemicals Company

Published on 2004-09-29. Author : SpecialChem

SANTA ANA, Calif. -- VitroTech Corporation (OTC Bulletin Board: VROT - News) announced receipt of the first production order of Vitrolite® from a global leader in the field of specialty chemicals.

The order follows several years of research, development and product tests in which Vitrolite® underwent intense scrutiny in a number of the customer's facilities. The initial order was shipped from the inventory of a Vitrolite® distributor which is in close proximity to the customer's production facility.

VitroTech Chief Executive Officer, Glenn Easterbrook, said, "We are excited about the acceptance of Vitrolite® by a respected global manufacturer. It is a tremendous accomplishment for our entire sales and technical team to finally gain the acceptance of this multi-billion dollar company and we hope to expand the use of Vitrolite® within the customer's organization to multiple divisions, facilities and product lines."

About VitroTech Corporation

VitroTech Corporation (OTC Bulletin Board: VROT - News) is a materials technology and research company, headquartered in Santa Ana, California, with rights to purchase, process and sell approximately 35 billion pounds of rare amorphous aluminosilicate deposits, which are used to produce its primary products, Vitrolite® and Vitrocote®. These products enhance both the physical qualities and production of plastics, paint/coatings, and a variety of other market segments.

Forward-Looking Statements

This news release contains forward-looking statements, which are based on current operations, plans and expectations. Actual results, including VitroTech's ability to increase the sales of Vitrolite® within the customer organization, may differ materially from these statements due to risks and uncertainties beyond the Company's control. For further information regarding risks and uncertainties associated with VitroTech's business, please refer to the "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors That May Affect Future Results" sections of VitroTech's SEC filings, including, but not limited to, its annual report on Form 10-KSB and quarterly reports on Form 10-QSB. All information in this release is as of September 27, 2004. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

Source: VitroTech Corporation

Omya Calcium Carboantes
Channel Alerts

Receive weekly digests on hot topics

Back to Top